Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PJ Online | News: Legal reclassifications sought

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7212 p238
24 August 2002

This article
Reprint
Photocopy


News summary

Related websites
Medicines Control Agency (www.mca.gov.uk)


Legal reclassifications sought

VIEWS on the reclassification of Grisol 1 per cent spray (griseofulvin) for the topical treatment of fungal infections and Hc45 bite and sting relief cream (1 per cent hydrocortisone) are being sought by the Medicines Control Agency.

Grisol is a prescription medicine which the manufacturer (Transdermal) wants to be available from pharmacies and Hc45 is a pharmacy medicine which Crookes wants to be available on general sale. So far as Grisol is concerned, the MCA says that the safety of griseofulvin has been established for many years and that the topical use of the product raises no new safety concerns, particularly with respect to acquired resistance or percutaneous absorption.

The MCA view on the reclassification of Hc45 is that there are no safety issues, provided the product's labels and leaflets give clear advice about its correct use. However, it wants the name changed to Hc45 bite and sting relief cream to avoid confusion with E45.

Consultation on both reclassification applications runs until 30 September 2002. Comments can be sent to Amanda Lawrence, Reclassifications Manager, Medicines Control Agency, Room 14-152 Market Towers, 1 Nine Elms Lane, London SW8 5NQ.

Back to Top

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20007518

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.